Mercedes Unzeta Selected Research

methylamine (methylammonium)

7/2014	Neuroprotective effects of the MAO-B inhibitor, PF9601N, in an in vivo model of excitotoxicity.
6/2008	Anti-apoptotic effect of Mao-B inhibitor PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+-treated SH-SY5Y human dopaminergic cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mercedes Unzeta Research Topics

Disease

25	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 03/2002
8	Parkinson Disease (Parkinson's Disease) 01/2016 - 08/2002
7	Stroke (Strokes) 03/2021 - 07/2010
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 06/2008
5	Inflammation (Inflammations) 03/2021 - 05/2013
4	Cognitive Dysfunction 01/2017 - 03/2012
3	Ischemic Stroke 01/2019 - 07/2010
3	Infarction (Infarctions) 01/2019 - 07/2010
3	Gliosis 01/2017 - 02/2009
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2021 - 06/2013
2	Brain Ischemia (Cerebral Ischemia) 02/2018 - 01/2014
2	Brain Injuries (Brain Injury) 02/2018 - 02/2009
2	Atherosclerosis 01/2018 - 11/2011
2	Neuroinflammatory Diseases 01/2016 - 01/2008
2	Hemorrhagic Stroke 01/2014 - 01/2012
2	Hemorrhage 01/2014 - 07/2010
2	Neuroblastoma 10/2013 - 12/2004
2	Nervous System Diseases (Neurological Disorders) 06/2013 - 03/2012
1	Herpes Zoster 01/2019
1	Hypertension (High Blood Pressure) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Amyloid Plaque 01/2016
1	Memory Disorders (Memory Loss) 01/2016
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 02/2015
1	Body Weight (Weight, Body) 07/2014
1	Hepatic Encephalopathy 07/2014
1	Liver Diseases (Liver Disease) 07/2014
1	Acute Liver Failure (Fulminant Hepatic Failure) 07/2014
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2014
1	Multiple Sclerosis 04/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2013
1	Diabetes Mellitus 10/2012

Drug/Important Bio-Agent (IBA)

15	Monoamine Oxidase (MAO)IBA 01/2020 - 08/2002
10	human AOC3 proteinIBA 03/2021 - 07/2010
7	Donepezil (Aricept)FDA LinkGeneric 01/2017 - 12/2011
6	N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA 03/2017 - 10/2013
6	N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamineIBA 01/2016 - 12/2004
6	Cholinesterases (Cholinesterase)IBA 06/2014 - 12/2011
5	EnzymesIBA 02/2018 - 11/2011
5	Amine Oxidase (Copper-Containing)IBA 02/2018 - 03/2002
5	LigandsIBA 03/2017 - 06/2013
5	Oxidoreductases (Dehydrogenase)IBA 01/2017 - 06/2012
5	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 06/2014 - 12/2011
4	Pharmaceutical PreparationsIBA 01/2017 - 09/2011
4	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 12/2004
4	AminesIBA 07/2014 - 12/2011
3	Proteins (Proteins, Gene)FDA Link 02/2018 - 01/2014
3	Scopolamine (Hyoscine)FDA Link 01/2017 - 01/2016
3	Biological ProductsIBA 01/2017 - 09/2011
3	AntioxidantsIBA 01/2016 - 12/2004
3	propargylamineIBA 01/2016 - 06/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 05/2013
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018 - 01/2009
2	Amyloid (Amyloid Fibrils)IBA 01/2017 - 01/2016
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2017 - 01/2014
2	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2016 - 04/2015
2	methylamine (methylammonium)IBA 07/2014 - 06/2008
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2014 - 07/2010
2	InterleukinsIBA 04/2013 - 01/2008
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 06/2012 - 09/2011
2	Therapeutic UsesIBA 01/2011 - 07/2010
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 02/2003 - 08/2002
1	Multifunctional EnzymesIBA 03/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	Tight Junction ProteinsIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Claudin-5IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 02/2018
1	CholesterolIBA 02/2018
1	E-SelectinIBA 02/2018
1	Simvastatin (Zocor)FDA LinkGeneric 02/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Apolipoproteins E (ApoE)IBA 01/2018
1	PXS-4728AIBA 01/2018
1	AldehydesIBA 01/2018
1	Serotonin ReceptorsIBA 01/2017
1	Tacrine (Cognex)FDA Link 01/2017
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2017
1	TheobromineIBA 04/2015
1	Kainic Acid (Kainate)IBA 07/2014
1	Urea (Carbamide)FDA LinkGeneric 07/2014
1	MetalsIBA 06/2014
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 06/2014
1	Chelating AgentsIBA 06/2014
1	AmidesIBA 03/2014
1	Carboxylic AcidsIBA 03/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	HydrazinesIBA 06/2013
1	indoleIBA 06/2013
1	PolyphenolsIBA 03/2012

Therapy/Procedure

5	Therapeutics 03/2017 - 09/2011
1	Surgical Portacaval Shunt (Portacaval Anastomosis) 07/2014
1	Transplantation 07/2014